JezK

Edit File: 1598095150.M386667P3154703.mocha3025.mochahost.com,S=87443,W=89211:2,S

Envelope-to: ahf-finance@jack.ngo,
 dr.safar@jack.ngo,
 finance.manager@jack.ngo,
 ghani@jack.ngo,
 hadi@jack.ngo,
 hafiz@jack.ngo,
 hamdard@jack.ngo,
 haseeb.shirzada@jack.ngo,
 mirzaee@jack.ngo,
 musawy@jack.ngo,
 nooromari@jack.ngo,
 pharmacy.kdz@jack.ngo,
 saqib@jack.ngo,
 takal@jack.ngo
Delivery-date: Sat, 22 Aug 2020 07:19:10 -0400
From: <ahmad@jack.ngo>
To: <hafiz@jack.ngo>,
	"'musawy'" <musawy@jack.ngo>,
	<ghani@jack.ngo>
Cc: <finance.manager@jack.ngo>,
	<ahf-finance@jack.ngo>,
	<hadi@jack.ngo>,
	"'Shirzada'" <haseeb.shirzada@jack.ngo>,
	<hamdard@jack.ngo>,
	"'Nooromari'" <nooromari@jack.ngo>,
	<dr.safar@jack.ngo>,
	"'Sardar Wali Takal'" <takal@jack.ngo>,
	<pharmacy.kdz@jack.ngo>,
	<saqib@jack.ngo>,
	<mirzaee@jack.ngo>
References: <005a01d67701$8dde3130$a99a9390$@jack.ngo> <003401d677eb$0e7d4940$2b77dbc0$@jack.ngo> <000901d67860$d67cb960$83762c20$@jack.ngo> <001601d67870$0a19c6a0$1e4d53e0$@jack.ngo>
In-Reply-To: <001601d67870$0a19c6a0$1e4d53e0$@jack.ngo>
Subject: RE: Medicine of AHF
Date: Sat, 22 Aug 2020 15:49:02 +0430
Message-ID: <00d701d67876$0d9cc420$28d64c60$@jack.ngo>
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_00D8_01D6789B.C593A560"
Thread-Index: AQN+pP+2z87vNQPs/+H5nxjOnGzc4AIF8yeTAQB6VcgAhw7wf6XXNQeA
Content-Language: en-us

This is a multipart message in MIME format.

------=_NextPart_000_00D8_01D6789B.C593A560
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_00D9_01D6789B.C593A560"

------=_NextPart_001_00D9_01D6789B.C593A560
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

Dear Mosavi Sahib,=20

=20

Please ask warehouse officer and follow this issue very seriously , =
because the remain supply from first supply of medicines are not =
received as the pharmacy assistant of Trauma care said , so please =
follow and confirm us ASAP.=20

=20

With Best Regards,

=20

Dr.Noor Ahmad =E2=80=9CAhmad=E2=80=9D MD,PGD (Leadership) PGD (NMD), PMP

Program Manager=20

Just for Afghan Capacity and Knowledge       =D8=A8=D9=84=D9=86=D8=AF =
=D8=A8=D8=B1=D8=AF=D9=86 =D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =
=D9=88 =D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9) =20

Address: First Street of Karta-e-Chahar, Kabul Afghanistan=20

Behind AWCC Main Office, House # 08

Ph: +93 +93(0)748480909=20

Email: ahmad <mailto:ahmad@jack.ngo> @jack.ngo =20

Website:www.jack.ngo=20

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

This e-mail and any files transmitted with it may contain privileged or =
confidential information. It is solely for use by the individual for =
whom it is intended, even if addressed incorrectly. If you received this =
e-mail in error, please notify the sender; do not disclose copy, =
distribute, or take any action in reliance on the contents of this =
information; and delete it from your system. Any other use of this =
e-mail is prohibited. The views expressed herein are those of the author =
and do not necessarily reflect the views or policies of jack =
(Afghanistan). Electronic transmissions may be recorded and =
monitored.For Verification Please Read the Barcode Reader. =20

=09
	=09
=20

=20

P Every 3000 sheets of paper costs us a tree. Please don't print this =
e-mail unless you really need to

=20

From: hafiz@jack.ngo [mailto:hafiz@jack.ngo]=20
Sent: Saturday, August 22, 2020 3:06 PM
To: 'musawy' <musawy@jack.ngo>; ghani@jack.ngo
Cc: finance.manager@jack.ngo; ahf-finance@jack.ngo; hadi@jack.ngo; =
'Shirzada' <haseeb.shirzada@jack.ngo>; hamdard@jack.ngo; 'Nooromari' =
<nooromari@jack.ngo>; ahmad@jack.ngo; dr.safar@jack.ngo; 'Sardar Wali =
Takal' <takal@jack.ngo>; pharmacy.kdz@jack.ngo; saqib@jack.ngo; =
mirzaee@jack.ngo
Subject: RE: Medicine of AHF

=20

Dear Dr. Musawi=20

The Nahib Hamza company had sent you the medicine  of AHF Project  and =
you sent us the receipt and the rest of the medicine we forced the Nahib =
Hamza  company to send  it immediately and they also sent the medicine =
and now  show us how many medicines were sent  at what time and when in =
the book registered and also send me the  GRN soon

=20

From: pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> =
[mailto:pharmacy@jack.ngo]=20
Sent: Saturday, August 22, 2020 1:17 PM
To: pharmacy.kdz@jack.ngo <mailto:pharmacy.kdz@jack.ngo> ; =
ghani@jack.ngo <mailto:ghani@jack.ngo> ; 'musawy'
Cc: finance.manager@jack.ngo <mailto:finance.manager@jack.ngo> ; =
ahf-finance@jack.ngo <mailto:ahf-finance@jack.ngo> ; hadi@jack.ngo =
<mailto:hadi@jack.ngo> ; 'Shirzada'; hamdard@jack.ngo =
<mailto:hamdard@jack.ngo> ; 'Nooromari'; ahmad@jack.ngo =
<mailto:ahmad@jack.ngo> ; dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> ; =
'Sardar Wali Takal'; 'hafiz'
Subject: RE: Medicine of AHF

=20

Dear Kunduz Colleagues,

Please always follow the reception procedure that you should not face =
any issue in future:

-          When a purchase order is raised, Kabul team will inform you =
for its details.

-          When items are physically arrived in Kunduz warehouse, you =
should assign a committee to check the items quantity and quality.

-          The committee to sign in GRN.

-          A scan copy of GRN to be sent to Kabul and original to be =
kept in your filling system.

-          GRN to be updated when some missing portion of original order =
arrived later.

=20

With best regards

JACK KBL Pharmacy Team

From: ahmad@jack.ngo <mailto:ahmad@jack.ngo> [mailto:ahmad@jack.ngo]=20
Sent: Friday, August 21, 2020 11:14 PM
To: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> ; hamdard@jack.ngo =
<mailto:hamdard@jack.ngo> ; 'Sardar Wali Takal' <takal@jack.ngo =
<mailto:takal@jack.ngo> >; takal@jack.af <mailto:takal@jack.af> ; =
'hafiz' <hafiz@jack.ngo <mailto:hafiz@jack.ngo> >
Cc: pharmacy.kdz@jack.ngo <mailto:pharmacy.kdz@jack.ngo> ; =
pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> ; logistic.manager@jack.ngo =
<mailto:logistic.manager@jack.ngo> ; finance.manager@jack.ngo =
<mailto:finance.manager@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; hadi@jack.ngo <mailto:hadi@jack.ngo> ; =
'Shirzada' <haseeb.shirzada@jack.ngo <mailto:haseeb.shirzada@jack.ngo> =
>; hamdard@jack.ngo <mailto:hamdard@jack.ngo> ; 'Nooromari' =
<nooromari@jack.ngo <mailto:nooromari@jack.ngo> >
Subject: RE: Medicine of AHF

=20

Dear Safar Sahib,=20

=20

First let me to thank you for the follow up ,this very important issue; =
secondly pharmacy teams in provincial and main offices are responsible =
to answer us and give us the acceptable justification; and moreover the =
medicines which are mentioned below are must to be find.=20

=20

Dear Dr. Hafiz,=20

=20

Please refer to below issue and follow with provincial pharmacy team to =
provide us the justification and present the medicines otherwise it is =
fraud.=20

=20

Dear Takal Sahib,=20

=20

For your information; some medicines which are purchased here for trauma =
care project and the pharmacy department here in main office said that =
we supplied them to Kunduz and the supplier which the name is clearly =
written in below email said too, that the medicine are supplied ; but =
pharmacy assistant of trauma project is not aware and the medicines are =
not in stock , GRN is not existed and even there is no any documents; so =
this is a serious issue ; your follow up is also needed.=20

=20

With Best Regards,

=20

Dr.Noor Ahmad =E2=80=9CAhmad=E2=80=9D MD,PGD (Leadership) PGD (NMD), PMP

Program Manager=20

Address: First Street of Karta-e-Chahar, Kabul Afghanistan=20

Behind AWCC Main Office, House # 08

Ph: +93 +93(0)748480909=20

Email: ahmad <mailto:ahmad@jack.ngo> @jack.ngo =20

Website:www.jack.ngo=20

=09
	=09
=20

=20

P Every 3000 sheets of paper costs us a tree. Please don't print this =
e-mail unless you really need to

=20

From: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> =
[mailto:dr.safar@jack.ngo]=20
Sent: Thursday, August 20, 2020 7:22 PM
To: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hamdard@jack.ngo =
<mailto:hamdard@jack.ngo>=20
Cc: pharmacy.kdz@jack.ngo <mailto:pharmacy.kdz@jack.ngo> ; =
pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> ; logistic.manager@jack.ngo =
<mailto:logistic.manager@jack.ngo> ; finance.manager@jack.ngo =
<mailto:finance.manager@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; hadi@jack.ngo <mailto:hadi@jack.ngo> ; =
'Shirzada' <haseeb.shirzada@jack.ngo <mailto:haseeb.shirzada@jack.ngo> =
>; takal@jack.ngo <mailto:takal@jack.ngo> ; hamdard@jack.ngo =
<mailto:hamdard@jack.ngo>=20
Subject: Medicine of AHF

=20

Dear Dr Sahib Ahmad

I hope my email finds you in good health

=20

I am writing this email for clarification, not for allegations.=20

=20

Today when I asked AHF Pharmacy assistant about the medicine not =
received, he was not sure that which one was received or which one was =
not received, after departure of Dr Jamal (Kunduz Warehouse officer), =
Hakim Mangal couldn=E2=80=99t provide us the GRNs of the medicine which =
were not received in 19th June but it is certain that maybe some items =
of not received medicine were received in the second time (29 June =
2020). Although Hakim Mangal is pharmacy assistant of AHF projects, he =
is not fully in the picture of medicine recevial for AHF Trauma project.

=20

When Hakim Mangal contacted with the Supplier, Naib Hamza, they claimed =
that they have even sent the Serum (100 box), they even have the =
confirmation paper.

=20

And also Dr Zulmay Hamdard is in the picture, I also asked him, he has =
no idea about the confirmation paper of Naib Hamza Company, but one =
thing is certain, that JACK PO Warehouse didn=E2=80=99t receive the =
serums.

=20

My request from Pharmacy Team is that kindly provide the GRNs of the =
medicine which were received second time (the left outs of first =
quarter). For better understanding please refer to below table. AHF =
Pharmacy Assistant Mr Hakim Mangal couldn=E2=80=99t provide.

=20

Name

Description

Unit

Quantity 1st Quarter (not received)

Cimetidine

Amp-200mg

Pcs

300

Ringer Lactate

Serum-1000 Ml

bags

2800

Gauze Compress

Non Sterile

Pcs

3750

Gloves

Sterile-Size 8

Pcs

750

Needle=20

Disposible-G19

Pcs

300

Tape

10cm

Pcs

120

=20

Thank you & Best Regards

=20

Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D MD/GP/Social Service Provider

Project Manager-AHF Project / NER PSEA Focal Point / Reach WoAA survey =
Focal Point

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93792 716 026 =E2=80=93 +93777 =
469 663 =E2=80=93 +93706 179 758

Official Email: Dr.Safar@jack.ngo <mailto:Dr.Safar@jack.ngo>=20

Personal Email: <mailto:Dr.Safar001@outlook.com> =
Dr.Safar001@outlook.com =E2=80=93 Dr.Safar@yahoo.com =
<mailto:Dr.Safar@yahoo.com>=20

Website:www.jack.ngo

=09
	=09

=20

------=_NextPart_001_00D9_01D6789B.C593A560
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head><meta =
http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8"><meta =
name=3DGenerator content=3D"Microsoft Word 15 (filtered medium)"><style></style></head><body lang=3DEN-US =
link=3D"#0563C1" vlink=3D"#954F72"><div class=3DWordSection1>Dear Mosavi Sahib, =
<o:p></o:p><o:p>&nbsp;</o:p>Please ask warehouse =
officer and follow this issue very seriously , because the remain supply =
from first supply of medicines are not received as the pharmacy =
assistant of Trauma care said , so please follow and confirm us ASAP. =
<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p>With Best =
Regards,<o:p></o:p><o:p>&nbsp;</o:p><img width=3D49 =
height=3D38 id=3D"_x0000_i1027" =
src=3D"cid:image006.jpg@01D6789B.C1A02410" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr.Noor Ahmad =E2=80=9CAhmad=E2=80=9D =
MD,PGD (Leadership) PGD (NMD), =
PMP<o:p></o:p>Program Manager =
<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: First Street of Karta-e-Chahar, Kabul =
Afghanistan <o:p></o:p>Behind AWCC Main Office, House # =
08<o:p></o:p>Ph: +93 +93(0)748480909 =
<o:p></o:p>Email: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&nbsp; <o:p></o:p>Website:www.jack.ngo <o:p></o:p>=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
<o:p></o:p>This e-mail and any files =
transmitted with it may contain privileged or confidential information. =
It is solely for use by the individual for whom it is intended, even if =
addressed incorrectly. If you received this e-mail in error, please =
notify the sender; do not disclose copy, distribute, or take any action =
in reliance on the contents of this information; and delete it from your =
system. Any other use of this e-mail is prohibited. The views expressed =
herein are those of the author and do not necessarily reflect the views =
or policies of jack (Afghanistan). Electronic transmissions may be =
recorded and monitored.For Verification Please Read =
the Barcode Reader.&nbsp; <o:p></o:p><![if !vml]><table cellpadding=3D0 cellspacing=3D0 =
align=3Dleft><tr><td width=3D6 =
height=3D251></td></tr><tr><td></td><td><img width=3D92 height=3D92 =
src=3D"cid:image008.jpg@01D6789B.C1A02410" alt=3D"jack smart code" =
v:shapes=3D"_x0000_s1028"></td></tr></table><![endif]><o:p>&nbsp;</o:p></=
p><o:p>&nbsp;</o:p><o:p>&nbsp;</=
o:p><o:p>&nbsp;</=
o:p> P<s=
pan =
style=3D'font-size:7.5pt;font-family:"Arial",sans-serif;color:green'> =
Ever=
y 3000 sheets of paper costs us a tree. Please don't print this e-mail =
unless you really need to<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: hafiz@jack.ngo =
[mailto:hafiz@jack.ngo] Sent: Saturday, August 22, 2020 3:06 =
PM To: 'musawy' &lt;musawy@jack.ngo&gt;; =
ghani@jack.ngo Cc: finance.manager@jack.ngo; =
ahf-finance@jack.ngo; hadi@jack.ngo; 'Shirzada' =
&lt;haseeb.shirzada@jack.ngo&gt;; hamdard@jack.ngo; 'Nooromari' =
&lt;nooromari@jack.ngo&gt;; ahmad@jack.ngo; dr.safar@jack.ngo; 'Sardar =
Wali Takal' &lt;takal@jack.ngo&gt;; pharmacy.kdz@jack.ngo; =
saqib@jack.ngo; mirzaee@jack.ngo Subject: RE: Medicine of =
AHF<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr. Musawi <o:p></o:p>The Nahib Hamza company =
had sent you the medicine&nbsp; of AHF Project&nbsp; and you sent us the =
receipt and the rest of the medicine we forced the Nahib Hamza =
&nbsp;company to send&nbsp; it immediately and they also sent the =
medicine and now&nbsp; show us how many medicines were sent &nbsp;at =
what time and when in the book registered and also send me the&nbsp; GRN =
soon<o:p></o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a> [<a =
href=3D"mailto:pharmacy@jack.ngo">mailto:pharmacy@jack.ngo</a>] =
 Sent: Saturday, August 22, 2020 1:17 PM To: <a =
href=3D"mailto:pharmacy.kdz@jack.ngo">pharmacy.kdz@jack.ngo</a>; <a =
href=3D"mailto:ghani@jack.ngo">ghani@jack.ngo</a>; =
'musawy' Cc: <a =
href=3D"mailto:finance.manager@jack.ngo">finance.manager@jack.ngo</a>; =
<a href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; 'Shirzada'; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>; 'Nooromari'; <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>; 'Sardar Wali =
Takal'; 'hafiz' Subject: RE: Medicine of =
AHF<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Kunduz Colleagues,<o:p></o:p>Please always follow the =
reception procedure that you should not face any issue in =
future:<o:p></o:p><![if =
!supportLists]>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>When a purchase order is raised, Kabul team will =
inform you for its details.<o:p></o:p><![if !supportLists]>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>When items are physically arrived in Kunduz =
warehouse, you should assign a committee to check the items quantity and =
quality.<o:p></o:p><![if =
!supportLists]>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>The committee to sign in =
GRN.<o:p></o:p><![if =
!supportLists]>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>A scan copy of GRN to be sent to Kabul and =
original to be kept in your filling system.<o:p></o:p><![if !supportLists]>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>GRN to be updated when some missing portion of =
original order arrived later.<o:p></o:p><o:p>&nbsp;</o:p>With best =
regards<o:p></o:p>JACK KBL Pharmacy =
Team<o:p></o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a> [<a =
href=3D"mailto:ahmad@jack.ngo">mailto:ahmad@jack.ngo</a>] =
 Sent: Friday, August 21, 2020 11:14 PM To: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>; 'Sardar Wali =
Takal' &lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; <a =
href=3D"mailto:takal@jack.af">takal@jack.af</a>; 'hafiz' &lt;<a =
href=3D"mailto:hafiz@jack.ngo">hafiz@jack.ngo</a>&gt; Cc: <a =
href=3D"mailto:pharmacy.kdz@jack.ngo">pharmacy.kdz@jack.ngo</a>; <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a>; <a =
href=3D"mailto:logistic.manager@jack.ngo">logistic.manager@jack.ngo</a>; =
<a =
href=3D"mailto:finance.manager@jack.ngo">finance.manager@jack.ngo</a>; =
<a href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; 'Shirzada' &lt;<a =
href=3D"mailto:haseeb.shirzada@jack.ngo">haseeb.shirzada@jack.ngo</a>&gt;=
; <a href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>; 'Nooromari' =
&lt;<a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a>&gt; Subje=
ct: RE: Medicine of AHF<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Safar Sahib, <o:p></o:p><o:p>&nbsp;</o:p>First let me to thank =
you for the follow up ,this very important issue; secondly pharmacy =
teams in provincial and main offices are responsible to answer us and =
give us the acceptable justification; and moreover the medicines which =
are mentioned below are must to be find. <o:p></o:p><o:p>&nbsp;</o:p>Dear Dr. Hafiz, =
<o:p></o:p><o:p>&nbsp;</o:p>Please refer to below =
issue and follow with provincial pharmacy team to provide us the =
justification and present the medicines otherwise it is fraud. =
<o:p></o:p><o:p>&nbsp;</o:p>Dear Takal Sahib, =
<o:p></o:p><o:p>&nbsp;</o:p>For your information; =
some medicines which are purchased here for trauma care project and the =
pharmacy department here in main office said that we supplied them to =
Kunduz and the supplier which the name is clearly written in below email =
said too, that the medicine are supplied ; but pharmacy assistant of =
trauma project is not aware and the medicines are not in stock , GRN is =
not existed and even there is no any documents; so this is a serious =
issue ; your follow up is also needed. <o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p>With Best =
Regards,<o:p></o:p><o:p>&nbsp;</o:p><img border=3D0 =
width=3D49 height=3D38 id=3D"_x0000_i1025" =
src=3D"cid:image001.jpg@01D6789B.B4B91220" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr.Noor Ahmad =E2=80=9CAhmad=E2=80=9D =
MD,PGD (Leadership) PGD (NMD), =
PMP<o:p></o:p>Program Manager =
<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: First Street of Karta-e-Chahar, Kabul =
Afghanistan <o:p></o:p>Behind AWCC Main Office, House # =
08<o:p></o:p>Ph: +93 +93(0)748480909 =
<o:p></o:p>Email: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&nbsp; <o:p></o:p>Website:www.jack.ngo <o:p></o:p>=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
<o:p></o:p>This e-mail and any files =
transmitted with it may contain privileged or confidential information. =
It is solely for use by the individual for whom it is intended, even if =
addressed incorrectly. If you received this e-mail in error, please =
notify the sender; do not disclose copy, distribute, or take any action =
in reliance on the contents of this information; and delete it from your =
system. Any other use of this e-mail is prohibited. The views expressed =
herein are those of the author and do not necessarily reflect the views =
or policies of jack (Afghanistan). Electronic transmissions may be =
recorded and monitored.For Verification Please Read =
the Barcode Reader.&nbsp; <o:p></o:p><![if !vml]><table cellpadding=3D0 cellspacing=3D0 =
align=3Dleft><tr><td width=3D6 =
height=3D1197></td></tr><tr><td></td><td><img width=3D92 height=3D92 =
src=3D"cid:image010.jpg@01D6789B.C1A02410" alt=3D"jack smart code" =
v:shapes=3D"Picture_x0020_1"></td></tr></table><![endif]><o:p>&nbsp;</o:p></=
p><o:p>&nbsp;</o:p><o:p>&nbsp;</=
o:p><o:p>&nbsp;</=
o:p> P<s=
pan =
style=3D'font-size:7.5pt;font-family:"Arial",sans-serif;color:green'> =
Ever=
y 3000 sheets of paper costs us a tree. Please don't print this e-mail =
unless you really need to<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a> [<a =
href=3D"mailto:dr.safar@jack.ngo">mailto:dr.safar@jack.ngo</a>] =
 Sent: Thursday, August 20, 2020 7:22 PM To: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a> Cc: <a =
href=3D"mailto:pharmacy.kdz@jack.ngo">pharmacy.kdz@jack.ngo</a>; <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a>; <a =
href=3D"mailto:logistic.manager@jack.ngo">logistic.manager@jack.ngo</a>; =
<a =
href=3D"mailto:finance.manager@jack.ngo">finance.manager@jack.ngo</a>; =
<a href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; 'Shirzada' &lt;<a =
href=3D"mailto:haseeb.shirzada@jack.ngo">haseeb.shirzada@jack.ngo</a>&gt;=
; <a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a> Subject: =
Medicine of AHF<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr =
Sahib Ahmad<o:p></o:p>I hope my email finds you =
in good health<o:p></o:p><o:p>&nbsp;</o:p>I am =
writing this email for clarification, not for allegations. =
<o:p></o:p><o:p>&nbsp;</o:p>Today when I asked AHF Pharmacy assistant about the =
medicine not received, he was not sure that which one was received or =
which one was not received, after departure of Dr Jamal (Kunduz =
Warehouse officer), Hakim Mangal couldn=E2=80=99t provide us the GRNs of =
the medicine which were not received in 19th June but it is =
certain that maybe some items of not received medicine were received in =
the second time (29 June 2020). Although Hakim Mangal is pharmacy =
assistant of AHF projects, he is not fully in the picture of medicine =
recevial for AHF Trauma project.<o:p></o:p><o:p>&nbsp;</o:p>When Hakim =
Mangal contacted with the Supplier, Naib Hamza, they claimed that they =
have even sent the Serum (100 box), they even have the confirmation =
paper.<o:p></o:p><o:p>&nbsp;</o:p>And also Dr Zulmay Hamdard is in the picture, I also =
asked him, he has no idea about the confirmation paper of Naib Hamza =
Company, but one thing is certain, that JACK PO Warehouse =
didn=E2=80=99t receive the serums.<o:p></o:p><o:p>&nbsp;</o:p>My =
request from Pharmacy Team is that kindly provide the GRNs of the =
medicine which were received second time (the left outs of first =
quarter). For better understanding please refer to below table. AHF =
Pharmacy Assistant Mr Hakim Mangal couldn=E2=80=99t =
provide.<o:p></o:p><o:p>&nbsp;</o:p><table class=3DMsoNormalTable =
border=3D0 cellspacing=3D0 cellpadding=3D0 =
style=3D'border-collapse:collapse'><tr><td width=3D97 valign=3Dtop =
style=3D'width:77.9pt;border:solid windowtext =
1.0pt;background:#D9D9D9;padding:0in 5.4pt 0in 5.4pt'>Name<o:p></o:p></td><td width=3D104 =
valign=3Dtop style=3D'width:83.8pt;border:solid windowtext =
1.0pt;border-left:none;background:#D9D9D9;padding:0in 5.4pt 0in =
5.4pt'>Description<o:p></o:p></td><td =
width=3D81 valign=3Dtop style=3D'width:1.0in;border:solid windowtext =
1.0pt;border-left:none;background:#D9D9D9;padding:0in 5.4pt 0in =
5.4pt'>Unit<o:p></o:p></td><td =
width=3D188 valign=3Dtop style=3D'width:175.5pt;border:solid windowtext =
1.0pt;border-left:none;background:#D9D9D9;padding:0in 5.4pt 0in =
5.4pt'>Quantity 1st Quarter (not =
received)<o:p></o:p></td></tr><tr><td width=3D97 valign=3Dtop =
style=3D'width:77.9pt;border:solid windowtext =
1.0pt;border-top:none;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Cimetidine<o:p></o:p></td><td width=3D104 =
valign=3Dtop =
style=3D'width:83.8pt;border-top:none;border-left:none;border-bottom:soli=
d windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Amp-200mg<o:p></o:p></td><td width=3D81 =
valign=3Dtop =
style=3D'width:1.0in;border-top:none;border-left:none;border-bottom:solid=
 windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Pcs<o:p></o:p></td><td width=3D188 =
valign=3Dtop =
style=3D'width:175.5pt;border-top:none;border-left:none;border-bottom:sol=
id windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>300<o:p></o:p></td></tr><tr><td width=3D97 =
valign=3Dtop style=3D'width:77.9pt;border:solid windowtext =
1.0pt;border-top:none;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Ringer Lactate<o:p></o:p></td><td =
width=3D104 valign=3Dtop =
style=3D'width:83.8pt;border-top:none;border-left:none;border-bottom:soli=
d windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Serum-1000 Ml<o:p></o:p></td><td width=3D81 =
valign=3Dtop =
style=3D'width:1.0in;border-top:none;border-left:none;border-bottom:solid=
 windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>bags<o:p></o:p></td><td width=3D188 =
valign=3Dtop =
style=3D'width:175.5pt;border-top:none;border-left:none;border-bottom:sol=
id windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>2800<o:p></o:p></td></tr><tr><td width=3D97 =
valign=3Dtop style=3D'width:77.9pt;border:solid windowtext =
1.0pt;border-top:none;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Gauze Compress<o:p></o:p></td><td =
width=3D104 valign=3Dtop =
style=3D'width:83.8pt;border-top:none;border-left:none;border-bottom:soli=
d windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Non Sterile<o:p></o:p></td><td width=3D81 =
valign=3Dtop =
style=3D'width:1.0in;border-top:none;border-left:none;border-bottom:solid=
 windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Pcs<o:p></o:p></td><td width=3D188 =
valign=3Dtop =
style=3D'width:175.5pt;border-top:none;border-left:none;border-bottom:sol=
id windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>3750<o:p></o:p></td></tr><tr><td width=3D97 =
valign=3Dtop style=3D'width:77.9pt;border:solid windowtext =
1.0pt;border-top:none;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Gloves<o:p></o:p></td><td width=3D104 =
valign=3Dtop =
style=3D'width:83.8pt;border-top:none;border-left:none;border-bottom:soli=
d windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Sterile-Size 8<o:p></o:p></td><td =
width=3D81 valign=3Dtop =
style=3D'width:1.0in;border-top:none;border-left:none;border-bottom:solid=
 windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Pcs<o:p></o:p></td><td width=3D188 =
valign=3Dtop =
style=3D'width:175.5pt;border-top:none;border-left:none;border-bottom:sol=
id windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>750<o:p></o:p></td></tr><tr><td width=3D97 =
valign=3Dtop style=3D'width:77.9pt;border:solid windowtext =
1.0pt;border-top:none;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Needle <o:p></o:p></td><td width=3D104 =
valign=3Dtop =
style=3D'width:83.8pt;border-top:none;border-left:none;border-bottom:soli=
d windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Disposible-G19<o:p></o:p></td><td =
width=3D81 valign=3Dtop =
style=3D'width:1.0in;border-top:none;border-left:none;border-bottom:solid=
 windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Pcs<o:p></o:p></td><td width=3D188 =
valign=3Dtop =
style=3D'width:175.5pt;border-top:none;border-left:none;border-bottom:sol=
id windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>300<o:p></o:p></td></tr><tr><td width=3D97 =
valign=3Dtop style=3D'width:77.9pt;border:solid windowtext =
1.0pt;border-top:none;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Tape<o:p></o:p></td><td width=3D104 =
valign=3Dtop =
style=3D'width:83.8pt;border-top:none;border-left:none;border-bottom:soli=
d windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>10cm<o:p></o:p></td><td width=3D81 =
valign=3Dtop =
style=3D'width:1.0in;border-top:none;border-left:none;border-bottom:solid=
 windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Pcs<o:p></o:p></td><td width=3D188 =
valign=3Dtop =
style=3D'width:175.5pt;border-top:none;border-left:none;border-bottom:sol=
id windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>120<o:p></o:p></td></tr></table><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p>Thank you &amp; Best =
Regards<o:p></o:p><img border=3D0 width=3D61 height=3D48 =
id=3D"Picture_x0020_21" src=3D"cid:image007.jpg@01D6789B.B4B91220" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Project Manager-AHF Project / NER PSEA =
Focal Point / Reach WoAA survey Focal Point<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93792 716 026 =E2=80=93 +93777 469 663 =E2=80=93 +93706 179 =
758<o:p></o:p>Official Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>=
Personal Email: <a =
href=3D"mailto:Dr.Safar001@outlook.com">Dr.Safar001@outlook.com</a> =E2=80=93 <a =
href=3D"mailto:Dr.Safar@yahoo.com">Dr.Safar@yahoo.com</a><s=
pan style=3D'font-size:9.0pt;font-family:"Segoe =
UI",sans-serif;color:#548DD4'><o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
p class=3DMsoNormal>=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
<o:p></o:p>This e-mail and any files =
transmitted with it may contain privileged or confidential information. =
It is solely for use by the individual for whom it is intended, even if =
addressed incorrectly. If you received this e-mail in error, please =
notify the sender; do not disclose copy, distribute, or take any action =
in reliance on the contents of this information; and delete it from your =
system. Any other use of this e-mail is prohibited. The views expressed =
herein are those of the author and do not necessarily reflect the views =
or policies of jack (Afghanistan). Electronic transmissions may be =
recorded and monitored.For Verification Please Read =
the Barcode Reader.&nbsp; <![if !vml]><table cellpadding=3D0 cellspacing=3D0 =
align=3Dleft><tr><td width=3D6 =
height=3D1896></td></tr><tr><td></td><td><img width=3D92 height=3D92 =
src=3D"cid:image011.jpg@01D6789B.C1A02410" alt=3D"jack smart code" =
v:shapes=3D"Picture_x0020_2"></td></tr></table><![endif]><o:p></o:p><o:p>&nbsp;</o:p></div></body></html>
------=_NextPart_001_00D9_01D6789B.C593A560--

------=_NextPart_000_00D8_01D6789B.C593A560
Content-Type: image/jpeg;
	name="image001.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image001.jpg@01D6789B.B4B91220>
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------=_NextPart_000_00D8_01D6789B.C593A560
Content-Type: image/png;
	name="image002.png"
Content-Transfer-Encoding: base64
Content-ID: <image002.png@01D6789B.B4B91220>

iVBORw0KGgoAAAANSUhEUgAAASIAAAEiAQAAAAB1xeIbAAAABGdBTUEAALGOfPtRkwAAAAlwSFlz
AAAOxAAADsQBlSsOGwAAABl0RVh0U29mdHdhcmUATWljcm9zb2Z0IE9mZmljZX/tNXEAAAEMSURB
VGje7dnBDYMwDIVhSwzASKzOSAxQySWOE1pooIcYqdWfA1LCd3uynVLRL9YsKBQKhfoLJb4GlWkZ
1oOlnEyoaGUbXVw5rS9QoSpFYu/mEpMHhrpNvWSFulvlfoS6UZVc8kC46l+ojup9IufAruY2qova
LQ/s4r6K6qNsDkt52Fbn8bFLCBWgRNJJBqOdPOSYECpEpVaUwZZVHQ2oSOWVYMNYS02oHmoIFaB8
LJemlO9FtURQgcpyWTciZxMZFaGsKW0TuXUTRYUqr4mPv8BQkcqnQuOrDypClcKonQl1n7I7kKl0
L2p+7UT1V7kf5RIZtfUPCypEWS5bOM2JjOqvzhcKhUKhfl49AcZAJK+rvDc4AAAAAElFTkSuQmCC

------=_NextPart_000_00D8_01D6789B.C593A560
Content-Type: image/jpeg;
	name="image007.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image007.jpg@01D6789B.B4B91220>
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------=_NextPart_000_00D8_01D6789B.C593A560
Content-Type: image/jpeg;
	name="image006.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image006.jpg@01D6789B.C1A02410>
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------=_NextPart_000_00D8_01D6789B.C593A560
Content-Type: image/jpeg;
	name="image008.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image008.jpg@01D6789B.C1A02410>
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------=_NextPart_000_00D8_01D6789B.C593A560
Content-Type: image/jpeg;
	name="image010.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image010.jpg@01D6789B.C1A02410>
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=

------=_NextPart_000_00D8_01D6789B.C593A560
Content-Type: image/jpeg;
	name="image011.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image011.jpg@01D6789B.C1A02410>
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=

------=_NextPart_000_00D8_01D6789B.C593A560--